{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-21-017038","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2021-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.950286+00:00","generated_at":"2026-06-30T04:47:04.764082+00:00","sec_items":["5.02","5.07"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"DiaMedica Therapeutics elects two new directors at 2021 AGM","bullets":["Shareholders elected Amy Burroughs and Charles Semba, M.D. as directors effective immediately.","Burroughs will serve on Audit and Nominating & Governance committees; Semba on Audit and Compensation committees.","Four incumbent directors re-elected: Pilnik, Giuffre, Parsons, Pauls. All received >96% votes for.","Baker Tilly US, LLP appointed as independent auditor for FY2021 with 10,734,645 votes for, none against.","Quorum of 57.2% present; 10,748,667 shares voted out of 18,786,157 outstanding."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-21-017038","json":"https://secwatch.observer/filing/0001437749-21-017038.json","markdown":"https://secwatch.observer/filing/0001437749-21-017038.md","text":"https://secwatch.observer/filing/0001437749-21-017038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/dmtp20210715_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:47:04.764082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"240a696e1c","claim":"Charles Semba, M.D. was elected as director at DiaMedica Therapeutics Inc..","evidence_excerpt":"the Company’s shareholders elected each of Amy Burroughs and Charles Semba, M.D. as a director of the Company effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"456e57dd84","claim":"Amy Burroughs was elected as director at DiaMedica Therapeutics Inc..","evidence_excerpt":"the Company’s shareholders elected each of Amy Burroughs and Charles Semba, M.D. as a director of the Company effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}